Nanocarriers as an emerging platform for cancer therapy.

by Dan Peer, Jeffrey M Karp, Seungpyo Hong, Omid C Farokhzad, Rimona Margalit, Robert Langer
Nature nanotechnology ()


Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients. Several therapeutic nanocarriers have been approved for clinical use. However, to date, there are only a few clinically approved nanocarriers that incorporate molecules to selectively bind and target cancer cells. This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic. We detail the arsenal of nanocarriers and molecules available for selective tumour targeting, and emphasize the challenges in cancer treatment.

Cite this document (BETA)

Readership Statistics

1145 Readers on Mendeley
by Discipline
by Academic Status
33% Ph.D. Student
18% Student (Master)
9% Post Doc
by Country
3% United States
1% India
1% Canada

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in